Skeletal muscle atrophy is a debilitating condition that significantly affects quality of life and often lacks effective treatment options.Muscle atrophy can have various causes,including myogenic,neurogenic,and other...Skeletal muscle atrophy is a debilitating condition that significantly affects quality of life and often lacks effective treatment options.Muscle atrophy can have various causes,including myogenic,neurogenic,and other factors.Recent investigation has underscored a compelling link between the gut microbiota and skeletal muscle.Discerning the potential differences in the gut microbiota associated with muscle atrophy-related diseases,understanding their influence on disease development,and recognizing their potential as intervention targets are of paramount importance.This review aims to provide a comprehensive overview of the role of the gut microbiota in muscle atrophy-related diseases.We summarize clinical and pre-clinical studies that investigate the potential for gut microbiota modulation to enhance muscle performance and promote disease recovery.Furthermore,we delve into the intricate interplay between the gut microbiota and muscle atrophy-related diseases,drawing from an array of studies.Emerging evidence suggests significant differences in gut microbiota composition in individuals with muscle atrophy-related diseases compared with healthy individuals.It is conceivable that these alterations in the microbiota contribute to the pathogenesis of these disorders through bacterium-related metabolites or inflammatory signals.展开更多
基金Guangdong Basic and Applied Basic Research Foundation(2020B1515020046)“GDAS”Project of Science and Technology Development(2021GDASYL-20210102003)+4 种基金Natural Science Foundation of China(82072436 and 32130099)Outstanding Youth Fund of the Hunan Natural Science Foundation(2021JJ20045)Youth Innovation Promotion Association of the Chinese Academy of Sciences(2022370)Science and Technology Program of Hunan Province(2020NK2013)Key R&D Program of Guangxi Province(2021AB20063)。
文摘Skeletal muscle atrophy is a debilitating condition that significantly affects quality of life and often lacks effective treatment options.Muscle atrophy can have various causes,including myogenic,neurogenic,and other factors.Recent investigation has underscored a compelling link between the gut microbiota and skeletal muscle.Discerning the potential differences in the gut microbiota associated with muscle atrophy-related diseases,understanding their influence on disease development,and recognizing their potential as intervention targets are of paramount importance.This review aims to provide a comprehensive overview of the role of the gut microbiota in muscle atrophy-related diseases.We summarize clinical and pre-clinical studies that investigate the potential for gut microbiota modulation to enhance muscle performance and promote disease recovery.Furthermore,we delve into the intricate interplay between the gut microbiota and muscle atrophy-related diseases,drawing from an array of studies.Emerging evidence suggests significant differences in gut microbiota composition in individuals with muscle atrophy-related diseases compared with healthy individuals.It is conceivable that these alterations in the microbiota contribute to the pathogenesis of these disorders through bacterium-related metabolites or inflammatory signals.
